ATE403754T1 - Verfahren zur diagnose von fettleibigkeit - Google Patents
Verfahren zur diagnose von fettleibigkeitInfo
- Publication number
- ATE403754T1 ATE403754T1 AT04769490T AT04769490T ATE403754T1 AT E403754 T1 ATE403754 T1 AT E403754T1 AT 04769490 T AT04769490 T AT 04769490T AT 04769490 T AT04769490 T AT 04769490T AT E403754 T1 ATE403754 T1 AT E403754T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- diagnosis
- therapeutics
- intron
- polymorphism
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 101150099050 WAC gene Proteins 0.000 abstract 1
- 208000012696 congenital leptin deficiency Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000001022 morbid obesity Diseases 0.000 abstract 1
- 229940124706 obesity therapeutics Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03292202A EP1512752A1 (de) | 2003-09-08 | 2003-09-08 | Verfahren zur Diagnose von Fettleibigkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE403754T1 true ATE403754T1 (de) | 2008-08-15 |
Family
ID=34130370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04769490T ATE403754T1 (de) | 2003-09-08 | 2004-09-08 | Verfahren zur diagnose von fettleibigkeit |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070199082A1 (de) |
| EP (2) | EP1512752A1 (de) |
| AT (1) | ATE403754T1 (de) |
| DE (1) | DE602004015622D1 (de) |
| ES (1) | ES2311853T3 (de) |
| WO (1) | WO2005024063A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275568A1 (de) * | 2009-07-13 | 2011-01-19 | Universitätsklinikum Regensburg | Markersequenzen für Adipositas und deren Verwendung |
| KR101620274B1 (ko) * | 2015-08-11 | 2016-05-11 | 경북대학교 산학협력단 | 비만의 진단용 조성물 및 이의 용도 |
| KR101745297B1 (ko) * | 2017-02-02 | 2017-06-09 | 경북대학교 산학협력단 | 비만 진단용 조성물 및 이의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001237046A1 (en) * | 2000-02-17 | 2001-08-27 | President And Fellows Of Harvard College | Inhibition of mal-1, the keratinocyte lipid binding protein |
-
2003
- 2003-09-08 EP EP03292202A patent/EP1512752A1/de not_active Withdrawn
-
2004
- 2004-09-08 WO PCT/IB2004/003144 patent/WO2005024063A1/en not_active Ceased
- 2004-09-08 ES ES04769490T patent/ES2311853T3/es not_active Expired - Lifetime
- 2004-09-08 EP EP04769490A patent/EP1664344B1/de not_active Expired - Lifetime
- 2004-09-08 DE DE602004015622T patent/DE602004015622D1/de not_active Expired - Lifetime
- 2004-09-08 US US10/570,981 patent/US20070199082A1/en not_active Abandoned
- 2004-09-08 AT AT04769490T patent/ATE403754T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005024063A1 (en) | 2005-03-17 |
| EP1512752A1 (de) | 2005-03-09 |
| US20070199082A1 (en) | 2007-08-23 |
| EP1664344A1 (de) | 2006-06-07 |
| EP1664344B1 (de) | 2008-08-06 |
| DE602004015622D1 (de) | 2008-09-18 |
| ES2311853T3 (es) | 2009-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE399761T1 (de) | Verfahren zur herstellung von dinitrilen | |
| ATE486844T1 (de) | Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien | |
| ATE483972T1 (de) | Reagenzien und verfahren für krebsprognose und pathologische einstufung | |
| DE602007011864D1 (de) | Vorrichtung zur Interpolation von Verkehrsinformationen | |
| ATE519182T1 (de) | Verfahren zum segmentieren von leukozyten | |
| ATE408604T1 (de) | Verfahren zur herstellung von 1-alkyl-3- phenyluracilen | |
| DE602005019848D1 (de) | Verfahren zur herstellung von tad- getrocknetem ti | |
| ATE465277T1 (de) | Verfahren zur herstellung von leder | |
| DE602006008581D1 (de) | Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung | |
| DE502006007045D1 (de) | Verfahren zur herstellung von nitrilen durch eliminierungsreaktionen | |
| EP1928614A4 (de) | Verfahren zur diagnose von infektionen | |
| DE602004029061D1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
| ATE403754T1 (de) | Verfahren zur diagnose von fettleibigkeit | |
| ATE482189T1 (de) | Verfahren zur hydrocyanierung | |
| DE602004022472D1 (de) | Vorrichtung für Erkennung von Änderungsinformation | |
| DE602005027919D1 (de) | Vorrichtung zur Verhinderung einer lateralen Verschiebung für Stabilisatoren | |
| ATE356136T1 (de) | Verfahren zur herstellung von 1,2- diaminocyclohexan-platin(ii)-komplexen | |
| DE602006014106D1 (de) | Verfahren zur diagnose von prostatakrebs | |
| ATE444303T1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
| DE602004026151D1 (de) | Vorrichtung zur Abnahme von Medien für einen Medienausgeber | |
| DE502005001884D1 (de) | Verfahren zur Vergrößerung des Regelbereichs für die Gleichstellung von Einspritzmengenunterschieden | |
| EP1901066A4 (de) | Verfahren zur diagnose von morbus alzheimer unter verwendung von serumglykoprotein als biomarker | |
| DE602005015445D1 (de) | Verfahren zur auswahl bzw. gewinnung von pvmv-resistenten pflanzen | |
| AT501151B8 (de) | Verfahren zur ansteuerung von biegemaschinen | |
| ATE463562T1 (de) | Lp-pla2-aktivitätstest mit hohem durchsatz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |